| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | CTLA4 (Cytotoxic T Lymphocyte Associated Antigen 4) /CD152/CD/CD152 antigen/CD28/celiac disease 3/CELIAC3/CTLA-4/cytotoxic T-lymphocyte protein 4/Cytotoxic T-lymphocyte-associated antigen 4/cytotoxic T-lymphocyte-associated protein 4/GRD4/GSE/ICOS |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human CTLA4 (Cytotoxic T-lymphocyte protein 4) is a molecular target commonly studied in biomedical research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of CTLA4 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of CTLA4 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
CTLA4 (Cytotoxic T-lymphocyte protein 4) may also be referenced as CTLA4 (Cytotoxic T Lymphocyte Associated Antigen 4) /CD152/CD/CD152 antigen/CD28/celiac disease 3/CELIAC3/CTLA-4/cytotoxic T-lymphocyte protein 4/Cytotoxic T-lymphocyte-associated antigen 4/cytotoxic T-lymphocyte-associated protein 4/GRD4/GSE/ICOS in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how CTLA4 relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.
- Interpreting shifts in CTLA4 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
CTLA4 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Checkpoint Imbalance in Primary Glomerulopathies: Comparative Insights into IgA Nephropathy and Membranoproliferative Glomerulonephritis
IF: 5.2 Journal: Cells Author: Department of Experimental Immunology, Medical University of Lublin, Chod?ki 4a Street, 20-093 Lublin, Poland Cited Date: 2025-10-11
Gut Microbiota Mediator Level and Its Relation to Disease Activity in Ankylosing Spondylitis
IF: Journal: Archives of Rheumatology Author: Department of Physical Therapy and Rehabilitation, Medicana Avcilar Hospital, Gaziantep, Türkiye Cited Date: 2025-09-05